Gene expression profiles and recurrence in stage II colon cancer

被引：0
|
作者：
Meredith, K.
Siegel, E.
Sarniak, A.
Eschrich, S.
McLoughlin, J.
Nair, R.
Ly, Q.
Alvarado, M.
Lewis, J.
Jensen, E.
Yeatman, T.
Shibata, D.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2007年 / 50卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：711 / 711
页数：1
相关论文
共 50 条
  • [21] Novel colon cancer tumor suppressor gene, β-defensin 1, to predict recurrence in patients with stage II and III colon cancer.
    Labonte, Melissa Janae
    Bohanes, Pierre Oliver
    Yang, Dongyun
    Loupakis, Fotios
    Wilson, Peter M. D.
    Gerger, Armin
    Ning, Yan
    Wakatsuki, Takeru
    Zhang, Wu
    Benhaim, Leonor
    Ladner, Robert D.
    El-Khoueiry, Anthony B.
    El-Khoueiry, Rita
    Iqbal, Syma
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
    Kelley, Robin K.
    Venook, Alan P.
    CLINICAL COLORECTAL CANCER, 2011, 10 (02) : 73 - 80
  • [23] Gene expression profiling can predict the outcome of stage II colon cancer patients
    Nature Clinical Practice Oncology, 2007, 4 (1): : 4 - 5
  • [24] Prognostic value of folate-associated gene expression in stage II colon cancer
    Donia Kaidi
    Elisabeth Odin
    Yvonne Wettergren
    Elinor Bexe Lindskog
    Journal of Cancer Research and Clinical Oncology, 151 (2)
  • [25] Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer
    Steven R. Alberts
    Tiffany M. Yu
    Robert J. Behrens
    Lindsay A. Renfro
    Geetika Srivastava
    Gamini S. Soori
    Shaker R. Dakhil
    Rex B. Mowat
    John P. Kuebler
    George P. Kim
    Miroslaw A. Mazurczak
    John Hornberger
    PharmacoEconomics, 2014, 32 : 1231 - 1243
  • [26] Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer
    Alberts, Steven R.
    Yu, Tiffany M.
    Behrens, Robert J.
    Renfro, Lindsay A.
    Srivastava, Geetika
    Soori, Gamini S.
    Dakhil, Shaker R.
    Mowat, Rex B.
    Kuebler, John P.
    Kim, George P.
    Mazurczak, Miroslaw A.
    Hornberger, John
    PHARMACOECONOMICS, 2014, 32 (12) : 1231 - 1243
  • [27] Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
    Mayanagi, Shuhei
    Kashiwabara, Kosuke
    Honda, Michitaka
    Oba, Koji
    Aoyama, Toru
    Kanda, Mitsuro
    Maeda, Hiromichi
    Hamada, Chikuma
    Sadahiro, Sotaro
    Sakamoto, Junichi
    Saji, Shigetoyo
    Yoshikawa, Takaki
    DISEASES OF THE COLON & RECTUM, 2018, 61 (07) : 803 - 808
  • [28] Can CEA be a Risk Factor for Recurrence in Stage II Colon Cancer?
    Suwa, Toshiyuki
    Sakurai, Joe
    Ohtsubo, Takehito
    TUMOR BIOLOGY, 2008, 29 : 83 - 83
  • [29] Stratification of Stage II Colon Cancer Using Recurrence Prediction Value
    Mizuno, Shodai
    Shigeta, Kohei
    Kato, Yujin
    Okui, Jun
    Morita, Satoru
    Sonal, Swati
    Goldstone, Robert
    Berger, David
    Al-Masri, Rama
    Al-Masri, Mahmoud
    Tajima, Yuki
    Kikuchi, Hiroto
    Hirata, Akira
    Nakadai, Jumpei
    Baba, Hideo
    Sugiura, Kiyoaki
    Hoshino, Go
    Seo, Yuki
    Makino, Akitsugu
    Suzumura, Hirofumi
    Suzuki, Yoshiyuki
    Adachi, Yoko
    Shimada, Takehiro
    Kondo, Takayuki
    Matsui, Shimpei
    Seishima, Ryo
    Okabayashi, Koji
    Kitagawa, Yuko
    Kunitake, Hiroko
    ANNALS OF SURGERY, 2024, 280 (02) : 274 - 282
  • [30] Impact of Adjuvant Chemotherapy on Recurrence Risk in Stage II Colon Cancer
    Adesoye, T.
    Hu, C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S91 - S91
12345